Aug 09, 2023 / 12:30PM GMT
Operator
Good morning, everyone. My name is Chelsea, and I will be your conference operator. At this time, I'd like to welcome everyone to ANI Pharmaceuticals Second Quarter 2023 Financial Results. (Operator Instructions) As a reminder, this conference call is being recorded today, August 9, 2023.
It is now my pleasure to turn the floor over to Ms. Judy DiClemente, Investor Relations for ANI Pharmaceuticals. Ma'am, please go ahead.
Judy DiClemente -
Thank you, Chelsea. Welcome to ANI Pharmaceuticals' Q2 2023 Earnings Results Call. This is Judy DiClemente of Insight Communications, Investor Relations for ANI. With me on today's call are Nikhil Lalwani, President and Chief Executive Officer; and Stephen Carey, Chief Financial Officer. You can also access the webcast of this call through the Investors section of the ANI website at www.anipharmaceuticals.com.
Before we get started, I would like to remind everyone that any statements made on today's conference call that express a belief,
Q2 2023 ANI Pharmaceuticals Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot